This grant is for advancing our understanding of cancer inflammation through innovative molecular imaging. The National Institutes of Health invites R01 applications focused on developing and utilizing cutting-edge molecular imaging methods to gain fundamental, in-vivo insights into cancer inflammation. Recognizing the limitations of current in vitro and ex vivo approaches, this opportunity seeks to leverage molecular imaging probes for precise temporal and spatial resolution of inflammatory cellular physiology and molecular changes in response to treatment. Successful proposals will feature integrated imaging approaches and strong cross-field collaborations between cancer basic science researchers and imaging scientists, aiming to significantly enhance the scientific understanding of cancer-inflammation interactions.
Opportunity ID: 357002
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-311 |
| Funding Opportunity Title: | Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 06, 2024 |
| Last Updated Date: | Nov 06, 2024 |
| Original Closing Date for Applications: | Jan 07, 2028 |
| Current Closing Date for Applications: | Jan 07, 2028 |
| Archive Date: | Feb 12, 2028 |
| Estimated Total Program Funding: | $500,000 |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Special district governments Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education State governments For profit organizations other than small businesses County governments City or township governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory cellular physiology in cancers and of molecular changes in response to treatment. This FOA encourages applications that focus on developing integrated imaging approaches to interrogate the role of inflammation in cancer through strong cross-field collaboration between cancer basic science researchers and imaging scientists. These collaborations are expected to advance science and understanding of cancer inflammation interactions. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-311.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357002 Full Announcement-PAR-24-311 -> PAR-24-311-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288514 | Jan 05, 2025 | Jan 07, 2028 | View |
Package 1
Mandatory forms
357002 RR_SF424_5_0-5.0.pdf
357002 PHS398_CoverPageSupplement_5_0-5.0.pdf
357002 RR_OtherProjectInfo_1_4-1.4.pdf
357002 PerformanceSite_4_0-4.0.pdf
357002 RR_KeyPersonExpanded_4_0-4.0.pdf
357002 PHS398_ResearchPlan_5_0-5.0.pdf
357002 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357002 RR_Budget_3_0-3.0.pdf
357002 RR_SubawardBudget30_3_0-3.0.pdf
357002 PHS398_ModularBudget_1_2-1.2.pdf
357002 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
